KPTI
KARYOPHARM THERAPEUTICS INC
Latest close $1.99 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Initial Schedule 13G | Initial Schedule 13G | 1.3M | 12.00% | $9.77 | $7.09 | $1.99 |
| T. Rowe Price Investment Management CIK0001897612 | May 31, 2026 observed Jun 5, 2026 filed · 5d Schedule 13G amendment | Reported reduction | 1.5M -705.3K | 12.00% 0.00 pts | $9.10 | $9.08 | $1.99 |
| T. Rowe Price Investment Management CIK0001897612 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Schedule 13G amendment | Earliest Schedule 13G amendment found | 2.2M | 12.00% | $7.36 | $9.40 | $1.99 |